Showing results (301-310 of 342) with videos related to
Sort By:
Pageof 35
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.Diagnostics (Basel, Switzerland)|September 9, 2023
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF StudyFilipa Curado, Sabine Rösner, Susanne Zielke, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseDaniel J Weisdorf, Gene Nelson, Stephanie J Lee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2025
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled TrialMichelle K Yong, Karin Thursky, Megan Crane, et al.Best Practice & Research. Clinical Haematology|December 13, 2023
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes RegistryLucy C Fox, Zoe K McQuilten, Frank Firkin, et al.Journal of Medical Genetics|October 26, 2019
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsyYoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, et al.Blood|June 24, 2004
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabineKenneth F Bradstock, Jane P Matthews, Raymond M Lowenthal, et al.Blood Cells, Molecules & Diseases|October 7, 2009
Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher diseaseCarla E M Hollak, Stephan vom Dahl, Johannes M F G Aerts, et al.Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 27, 2020
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease StudyAndrew J Cowan, Helen Baldomero, Yoshiko Atsuta, et al.Pageof 35